SRTA Share Price Performance
US$4.15
1.54 (59.00%)
48.1% undervalued intrinsic discount
US$8.00
Fair Value
Price US$4.15
AnalystLowTarget US$8.00
AnalystConsensusTarget US$9.63
AnalystHighTarget US$11.25
Fair ValueUS$8.00
Share Pricen/a
Strata Critical Medical, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 29 Fair Values set on narratives written by author
SRTA Community Narratives
AN
Fair Value US$8 48.1% undervalued intrinsic discount
Delays Will Slow Organ Transport Yet Offer Future Value
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$9.63 56.9% undervalued intrinsic discount
SRTA: Cash Deployment Through Acquisition Will Drive Expansion In Healthcare Reach
0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
AN
Fair Value US$11.25 63.1% undervalued intrinsic discount
Urbanization And Electrification Will Fuel On-Demand Medical Air Mobility
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Delays Will Slow Organ Transport Yet Offer Future Value
Key Takeaways Heavy dependence on organ transport growth and uncertain regulatory or technological adoption pose risks to revenue stability and margin expansion. Delays in eVTOL adoption or high fixed costs could constrain cost savings, while integration and environmental challenges may hamper long-term profit growth.Read more
35
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$8
48.1% undervalued intrinsic discount
Fair Value
Profit Margin
5.16%
Future PE
54.75x
Price in 2029
US$9.74
SRTA: Cash Deployment Through Acquisition Will Drive Expansion In Healthcare Reach
Key Takeaways Demand growth in medical transport and healthcare trends provide strong foundations for sustained revenue and margin expansion. Strategic partnerships and digital platforms enable cost advantages, defensible recurring revenue, and long-term market leadership potential.Read more
83
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
AN
US$9.63
56.9% undervalued intrinsic discount
Fair Value
Profit Margin
5.48%
Future PE
64.4x
Price in 2029
US$11.72
Urbanization And Electrification Will Fuel On-Demand Medical Air Mobility
Key Takeaways The focus on medical air mobility, technological innovation, and aggressive M&A strategy could rapidly accelerate market share and margin expansion. Strong financial position and streamlined operations enable robust free cash flow and flexibility for strategic investments or buybacks, supporting sustained earnings growth.Read more
10
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$11.25
63.1% undervalued intrinsic discount
Fair Value
Profit Margin
18.6%
Future PE
25.74x
Price in 2029
US$13.67
Trending Discussion
Recently Updated Narratives
AN
SRTA: Higher Revenue Outlook And Richer Future P/E Will Drive Upside
Fair Value: US$8 48.1% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SRTA: Higher Revenue Outlook And Impairment Charge Will Support Future Upside
Fair Value: US$9.63 56.9% undervalued intrinsic discount
14 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SRTA: Higher Margins And Updated Guidance Will Support Stronger Future Returns
Fair Value: US$11.25 63.1% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Strata Critical Medical, Inc. Key Details
About SRTA
- Founded
- 2014
- Employees
- 327
- CEO
- WebsiteView website
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
